Borosil Scientific Ltd
Borosil Scientific Ltd Q4 FY26 Results & Presentation Highlights: Revenue ₹143.2 Cr, PAT ₹21.5 Cr
Q4 FY26 investor presentation: what the company reported on revenue, margins and projects.
Based on Borosil Scientific Ltd's Q4 FY26 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.
The short version
Q4FY26 Consolidated Net Sales: ₹143.2 crores, up 10.6% YoY (Q4FY25: ₹129.5 crores) - Q4FY26 Standalone Net Sales: ₹131.9 crores, up 12.1% YoY (Q4FY25: ₹117.7 crores) - Category-wise Q4FY26 Sales Y Q4FY26 Financials (Standalone): - EBITDA: ₹31.5 crores, up 42.2% YoY - EBITDA Margin: 23.9% (compared to 18.8% in Q4FY25) - PAT: ₹21.5 crores, up 51.9% YoY - Q4FY26 Financials (Consolidated): - EBITDA: ₹32.4 crores, up 87.6% YoY - EBITDA Margin: 22.7% (compared to 13.4% in Q4FY25) - PAT: ₹27.2 crores, up 216.2% YoY - Margin Outlook: - The presentation targets improving EBITDA margins by focusing on high-margin segments such as Process Sciences and lab equipment, annual pricing strategies, expense control, and renewable energy initiatives (Page 20).
From Borosil Scientific Ltd's Q4 FY26 earnings-call transcript · updated 25 Sept 2026.
Revenue & Sales Performance
- Q4FY26 Consolidated Net Sales: ₹143.2 crores, up 10.6% YoY (Q4FY25: ₹129.5 crores)
- Q4FY26 Standalone Net Sales: ₹131.9 crores, up 12.1% YoY (Q4FY25: ₹117.7 crores)
- Category-wise Q4FY26 Sales YoY growth:
- Lab Consumables: ₹80.0 crores, +13.4% YoY
- Lab Equipment: ₹17.1 crores, +13.6% YoY
- Process Systems: ₹12.5 crores, +3.4% YoY
- Pharma Packaging: ₹18.0 crores, +3.9% YoY
- Domestic Glassware: ₹13.7 crores, +7.0% YoY
- FY26 Consolidated Net Sales: ₹467.3 crores, +6.6% YoY (FY25: ₹438.5 crores)
- FY26 Standalone Net Sales: ₹427.5 crores, +8.9% YoY (FY25: ₹392.5 crores)
2 more points management made on revenue & sales performance
Profitability & Margins
See what Borosil Scientific Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
2 more points management made on capital expenditure plans
Top-ranked in Industrial Products
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Borosil Scientific Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
Borosil Scientific Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹143 Cr, net profit ₹27 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Borosil Scientific Ltd's management said in earlier quarters
Others in Industrial Products this season
- JTL Defence Ltd (Q4 FY26)
Q4 FY26 Operating Margin (EBITDA margin):** 24.2% (not stated in Q4 FY25; marked as NM) . Key investor presentation takeaways from JTL Defence Ltd's Q4 FY26 inv
- Tirupati Forge Ltd (Q4 FY26)
. Key investor presentation takeaways from Tirupati Forge Ltd's Q4 FY26 investor presentation — and how it ranks against sector peers.
- India Homes Ltd (Q4 FY26)
Quarterly Revenue (Q4 FY26):** ₹24.48 crore from operations (real estate activities contributed ₹24.25 crore). Key investor presentation takeaways from India Ho
- Arrow Greentech Ltd (Q4 FY26)
Year-on-Year (YoY) Change: -27.1% . Key investor presentation takeaways from Arrow Greentech Ltd's Q4 FY26 investor presentation — and how it ranks against sect
Frequently Asked Questions
What were Borosil Scientific Ltd Q4 FY26 results?
Q4FY26 Consolidated Net Sales: ₹143.2 crores, up 10.6% YoY (Q4FY25: ₹129.5 crores) - Q4FY26 Standalone Net Sales: ₹131.9 crores, up 12.1% YoY (Q4FY25: ₹117.7 crores) - Category-wise Q4FY26 Sales Y Q4FY26 Financials (Standalone): - EBITDA: ₹31.5 crores, up 42.2% YoY - EBITDA Margin: 23.9% (compared to 18.8% in Q4FY25) - PAT: ₹21.5 crores, up 51.9% YoY - Q4FY26 Financials (Consolidated): - EBITDA: ₹32.4 crores, up 87.6% YoY - EBITDA Margin: 22.7% (compared to 13.4% in Q4FY25) - PAT: ₹27.2 crores, up 216.2% YoY - Margin Outlook: - The presentation targets improving EBITDA margins by focusing on high-margin segments such as Process Sciences and lab equipment, annual pricing strategies, expense control, and renewable energy initiatives (Page 20).
What is Borosil Scientific Ltd share price analysis?
Borosil Scientific Ltd currently shows a neutral. The stock trades at a P/E of 23.9 with a market cap of ₹1,064 Cr. Investors should review the full earnings analysis for detailed insights.
Is Borosil Scientific Ltd planning capital expenditure?
The presentation does not provide specific details on capex amounts, capacity expansions, or new plant/projects with timelines.
Keep Borosil Scientific Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.